An 80-year-old male patient, a known hypertensive and a chronic smoker presented to the hospital with effort angina for the last 3 months, and the pain has worsened since the last 3 days. ECG showed ST elevation in leads V2 to V4 and T wave inversion in leads V2-V6. Coronary angiogram revealed severe LMCA, LAD, and LCX disease. The LMCA was engaged with EBU 7Fr guiding catheter and a check angiogram revealed ostial LMCA 70% lesion, mid-LAD 90% lesion and LCX proximal 80% lesion ([Fig. 1](#fig0005){ref-type="fig"}A). The LAD lesion was crossed with Sion blue wire and a 0.014″ BMW Elite wire was placed in the LCX. Predilatation of LMCA lesion was done with 2.0 × 12 mm NC Trek balloon and the LAD lesion with 2.0 × 12 mm and 2.5 × 08 mm (NC Trek balloons). Prestenting IVUS (Intravascular ultrasound) was done with Atlantis SR pro 40 MHz 3.6Fr catheter. IVUS showed the LAD to have a minimal lumen area of 2.6 sq mm with 90% fibrotic plaque, a vessel size of 2.5 mm, and the LMCA to have a minimal lumen area of 8.8 sq mm with 70% fibrotic plaque and vessel size of 3.8 mm ([Fig. 1](#fig0005){ref-type="fig"}B). Mid-LAD stenting was done with 2.5 × 28 mm Absorb Stent (BVS) at 12 atms for 30 s and redilatation was done with the same stent balloon at 14 atms for 10 s ([Fig. 2](#fig0010){ref-type="fig"}A). Postdilatation was done with 2.75 × 12 mm NC Trek balloon. Predilatation of LCX lesion was done with 2.5 × 08 mm NC Trek balloon. Then stenting was performed with 3.0 × 28 mm Absorb Stent (BVS) at 12 atms for 30 s and redilatation was done with same stent balloon at 14 atms ([Fig. 2](#fig0010){ref-type="fig"}B). Check angiogram showed edge dissection proximal to the BVS Stent ([Fig. 2](#fig0010){ref-type="fig"}C), which was covered with 3.0 × 12 mm Xience Xpedtion Stent (DES) at 10 atms for 10 s and redilatation was done with same stent balloon at 14 atms for 10 s ([Fig. 2](#fig0010){ref-type="fig"}D). Then LMCA Stenting was done with 3.5 × 12 mm Absorb Stent at 14 atms for 20 s and redilatation done with same stent balloon at 18 atms for 15 s ([Fig. 2](#fig0010){ref-type="fig"}E). Postdilatation was done with 4.0 × 08 mm NC Trek balloon. Postdilatation of mid-LAD was done with 2.75 × 10 mm NC trek balloon. Poststenting LMCA--LAD IVUS was done ([Fig. 2](#fig0010){ref-type="fig"}F). LMCA and LAD Stents were well opposed without any dissection or residual stenosis. The final result was good with TIMI III Flow and no complication ([Fig. 3](#fig0015){ref-type="fig"}).

Conflict of interest {#sec0005}
====================

The authors have none to declare.

We thank Dr. Melvin George for his inputs in preparing the manuscript.

![(A) CAG-ostial LMCA 70% lesion, mid-LAD 90% lesion, and LCX proximal 80% lesion. (B) Prestenting IVUS-minimal lumen area of LAD 2.6 sq mm with 90% fibrotic plaque; vessel size is 2.5 mm and LMCA is 8.8 sq mm with 70% fibrotic plaque and vessel size is 3.8 mm.](gr1){#fig0005}

![(A) Mid-LAD Stenting done with 2.5 × 28 mm Absorb Stent (BVS). (B) LCX Stenting done with 3.0 × 28 mm Absorb Stent (BVS). (C) Check angiogram showed edge dissection proximal to the (BVS) Stent. (D) Dissection covered with 3.0 × 12 mm Xience Xpedtion Stent (DES). (E) LMCA Stenting done with 3.5 × 12 mm Absorb Stent. (F) Poststenting IVUS-well apposed stent struts, no residual stenosis.](gr2){#fig0010}

![Final TIMI III flow.](gr3){#fig0015}
